Word

REMARV

Status

Registered

Status Code

700

Status Date

Tuesday, March 6, 2018

Serial Number

87562404

Registration Number

5417688

Registration Date

Tuesday, March 6, 2018

Mark Type

4000

Filing Date

Wednesday, August 9, 2017

Published for Opposition

Tuesday, December 19, 2017

Trademark Owner History

Glaxo Group Limited - Original Registrant

Classifications

5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

The wording "REMARV" has no meaning in a foreign language.

Trademark Events

Mar 6, 2023

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Nov 8, 2022

Teas Change Of Correspondence Received

Nov 8, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Nov 8, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Mar 6, 2018

Registered-Principal Register

Dec 19, 2017

Official Gazette Publication Confirmation E-Mailed

Dec 19, 2017

Published For Opposition

Nov 29, 2017

Notification Of Notice Of Publication E-Mailed

Nov 9, 2017

Approved For Pub - Principal Register

Nov 2, 2017

Assigned To Examiner

Aug 15, 2017

New Application Office Supplied Data Entered

Aug 12, 2017

New Application Entered